The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
ABVC BioPharma Partners with OncoX BioPharma Inc. for Oncology Products
Dec 11, 2024•over 1 year ago
Contract Type
partnership
FremontBiotechnologyPharmaceuticalBiopharma
Description
ABVC BioPharma has secured a $200,000 cash licensing payment from OncoX BioPharma Inc., marking the first installment of a potential $5 million licensing fee. In total, ABVC has received $546,000 from its three strategic partners for licensing various products. This reinforces the shared vision of creating impactful treatments that address current oncology challenges and signifies a pivotal moment in the partnership with OncoX.
Company Information
Company
ABVC BioPharma
Location
44370 OLD WARM SPRINGS BLVD
Fremont, California, United States
About
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology. The company has an active pipeline of six drugs and one medical device (ABV-1701/Vitargus®) under development, utilizing in-licensed technology from its network of world-renowned research institutions to conduct proof-of-concept trials through Phase II of clinical development.
FremontBiotechnologyPharmaceuticalBiopharma